Replies to post #244258 on Biotech Values

[swampboots]

TCDA down to .56 cents from 11.84 high on Friday, and still may be too high?

[Whalatane]

TCDA. Over a $100 m loss for Venrock today ... and not a very happy day in this household either ....:--(
Kiwi

[dewophile]

Don’t change protocols dramatically from phase 2. It’s generally a bad idea. Sometimes very bad.

Perhaps you can add another maxim - moving to phase 3 after a failed phase 2 is most likely not going to result in a successful outcome

https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-contrast-phase-iii-programme-for-otilimab-in-the-treatment-of-moderate-to-severe-rheumatoid-arthritis/